EURL:ARCA-Direxion Daily FTSE Europe Bull 3x Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 20.8234

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the FTSE Developed Europe All Cap Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the FTSE Developed Europe All Cap Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is a market capitalization weighted index that is designed to measure the equity market performance of large-, mid- and small-cap companies in developed markets in Europe. The fund is non-diversified.

Inception Date: 22/01/2014

Primary Benchmark: FTSE Developed Europe All Cap NR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.96%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-29 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 7.96B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 7.84B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 5.60B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 4.27B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.43B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.61B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 1.16B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.91B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.82B

ETFs Containing EURL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.17% 14% F 17% F
Dividend Return 2.28% 84% B 37% F
Total Return -9.90% 14% F 17% F
Trailing 12 Months  
Capital Gain -12.17% 14% F 17% F
Dividend Return 2.28% 84% B 37% F
Total Return -9.90% 14% F 17% F
Trailing 5 Years  
Capital Gain -38.86% 33% F 14% F
Dividend Return 4.91% 79% B- 13% F
Total Return -33.96% 32% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain 24.19% 48% F 84% B
Dividend Return 25.51% 48% F 83% B
Total Return 1.32% 83% B 32% F
Risk Return Profile  
Volatility (Standard Deviation) 66.36% 60% D- 14% F
Risk Adjusted Return 38.44% 64% D 53% F
Market Capitalization 0.02B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.